Immune evasion in pancreatic cancer: from mechanisms to therapy

N Martinez-Bosch, J Vinaixa, P Navarro - Cancers, 2018 - mdpi.com
Pancreatic ductal adenocarcinoma (PDA), the most frequent type of pancreatic cancer,
remains one of the most challenging problems for the biomedical and clinical fields, with …

[HTML][HTML] Hepatocyte polarity

A Treyer, A Müsch - Comprehensive Physiology, 2013 - ncbi.nlm.nih.gov
Hepatocytes, like other epithelia, are situated at the interface between the organism's
exterior and the underlying internal milieu and organize the vectorial exchange of …

Emerging avenues linking inflammation and cancer

JK Kundu, YJ Surh - Free Radical Biology and Medicine, 2012 - Elsevier
The role of inflammation in carcinogenesis has been extensively investigated and well
documented. Many biochemical processes that are altered during chronic inflammation …

The progress of immune checkpoint therapy in primary liver cancer

Y Zheng, S Wang, J Cai, A Ke, J Fan - Biochimica et Biophysica Acta (BBA) …, 2021 - Elsevier
After years of in-depth research on immune checkpoints, therapeutic reversal of immune-
exhaustion with immune checkpoint inhibitors (ICPIs) has been shown to be effective in …

The universe of galectin-binding partners and their functions in health and disease

MF Troncoso, MT Elola, AG Blidner, L Sarrias… - Journal of Biological …, 2023 - ASBMB
Galectins, a family of evolutionarily conserved glycan-binding proteins, play key roles in
diverse biological processes including tissue repair, adipogenesis, immune cell …

Galectin-9 in tumor biology: a jack of multiple trades

R Heusschen, AW Griffioen, VL Thijssen - Biochimica et Biophysica Acta …, 2013 - Elsevier
Galectin family members have been shown to exert multiple roles in the context of tumor
biology. Several recent findings support a similar multi-faceted role for galectin-9. Galectin-9 …

Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression

P Carabias, MV Espelt, ML Bacigalupo, P Rojas… - Cell Death & …, 2022 - nature.com
Abstract Galectin-1 (GAL1), a β-galactoside-binding protein abundantly expressed in the
tumor microenvironment, has emerged as a key mechanism of chemoresistance developed …

Galectins in cancer and the microenvironment: functional roles, therapeutic developments, and perspectives

CH Li, YC Chang, MH Chan, YF Yang, SM Liang… - Biomedicines, 2021 - mdpi.com
Changes in cell growth and metabolism are affected by the surrounding environmental
factors to adapt to the cell's most appropriate growth model. However, abnormal cell …

Galectin-1-induced autophagy facilitates cisplatin resistance of hepatocellular carcinoma

YC Su, GVN Davuluri, CH Chen, DC Shiau, CC Chen… - PLoS …, 2016 - journals.plos.org
Hepatocellular carcinoma (HCC) is one of the most common cancers in Taiwan. Although
chemotherapy is the primary treatment for HCC patients, drug resistance often leads to …

Galectin‐1 triggers epithelial‐mesenchymal transition in human hepatocellular carcinoma cells

ML Bacigalupo, M Manzi, MV Espelt… - Journal of cellular …, 2015 - Wiley Online Library
Galectin‐1 (Gal1), a β‐galactoside‐binding protein abundantly expressed in tumor
microenvironments, is associated with the development of metastasis in hepatocellular …